[1]
K. M. Kotlarska, W. Kotlarski, T. Mainka, and E. . Sergejuk, “LABORATORY MONITORING OF METABOLIC SAFETY DURING CARIPRAZINE TREATMENT IN SCHIZOPHRENIA AND BIPOLAR DISORDER: A SYSTEMATIC REVIEW”, IJITSS, vol. 4, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5550.